Intrauterine growth restriction, brain-sparing effect, and neurotrophins

Annals of the New York Academy of Sciences

Volumn 1092, Issue , 2006, Pages 293-296

  Malamitsi Puchner, Ariadne ^a   Nikolaou, K E ^a   Puchner, K P ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Brainderived neurotrophic factor; Intrauterine growth restriction; Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPIN;

ADRENAL GLAND; BIRTH WEIGHT; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; FETOPLACENTAL UNIT; FETUS BLOOD; GESTATIONAL AGE; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; NEUROPROTECTION; OXYGEN CONSUMPTION; POSTNATAL DEVELOPMENT; PROTEIN FAMILY; BLOOD; FEMALE; PREGNANCY; REVIEW;

BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FETAL GROWTH RETARDATION; HUMANS; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEUROTROPHIN 3; PREGNANCY;

EID: 34247253784     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1365.026     Document Type: Conference Paper

References (27)

1. GARDOSI, J., A. CHANG, B. KALYAN, et al. 1992. Customised antenatal growth charts. Lancet 339: 283-287.
2. GARDOSI, J., M. MONGELLI, M. WILCOX, et al. 1995. An adjustable fetal weight standard. Ultrasound Obstet. Gynecol. 6: 168-174.
3. MOORE, L.G., M. SHRIVER, L. BEMIS, et al. 2004. Maternal adaptation to highaltitude pregnancy: an experiment of nature - a review. Placenta 25(Suppl A): S60-S71.
4. SOOTHILL, P.W., R.A. AJAYI & K.N. NICOLAIDES. 1992. Fetal biochemistry in growth retardation. Early Hum. Dev. 29: 91-97.
5. BARDE, Y.A. 1990. The nerve growth factor family. Prog. Growth Factor Res. 2: 237-248.
6. RESNIK, R. 2002. Intrauterine growth restriction. Obstet. Gynecol. 99: 490-496.
7. VILLE, Y. & D.A. NYBERG. 2003. Growth, Doppler and fetal assessment. In Diagnostic Imaging of Fetal Anomalies. D.A. Nyberg, J.P. McGahan, D.H. Pretorius & G. Pilu, Eds.: 31-58. Lippincott, Williams and Wilkins. Philadelphia.
8. PEEBLES, D.M. 2004. Fetal consequences of chronic substrate deprivation. Semin. Fetal Neonatal Med. 9: 379-386.
9. RICHARDSON, B.S. & A.D. BOCKING. 1998. Metabolic and circulatory adaptations to chronic hypoxia in the fetus. Comp. Biochem. Physiol. 119A: 717-723.
10. DUBIEL, M., A. SEREMAK-MROZIKIEWICZ, G.H. BREBOROWICZ, et al. 2005. Fetal and maternal Doppler velocimetry and cytokines in high-risk pregnancy. J. Perinat. Med. 33: 17-21.
11. HARKNESS, U.F. & G. MARI. 2004. Diagnosis and management of intrauterine growth restriction. Clin. Perinatol. 31: 743-764.
12. BRAEMS, G. & A. JENSEN. 1991. Hypoxia reduces oxygen consumption of fetal skeletal muscle cells in monolayer culture. J. Dev. Physiol. 16: 209-215.
13. ZAW, W., R. GAGNON & O. SILVA. 2003. The risks of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics 111: 1273-1277.
14. THORNTON, J.G., J. HORNBUCKLE, A. VAIL, et al. 2004. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 364: 513-520.
15. SCHERJON, S., J. BRIET, H. OOSTING, et al. 2000. The discrepancy between maturation of visual-evoked potentials and cognitive outcome at five years in very preterm infants with and without hemodynamic signs of fetal brain-sparing. Pediatrics 105: 385-391.
16. PAZ, I., R. GALE, A. LAOR, et al. 1995. The cognitive outcome of full-term small for gestational age infants at late adolescence. Obstet. Gynecol. 85: 452-456.
17. LEWIN, G. & Y.A. BARDE. 1996. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19: 289-317.
18. BARBACID, M. 1995. Neurotrophic factors and their receptors. Curr. Opin. Cell. Biol. 7: 148-155.
19. ARENAS, E. & H. PERSSON. 1994. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367: 368-371.
20. HEFTI, F. 1986. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6: 2155-2162.
21. HYMAN, C., M. HOFER, Y.A. BARDE, et al. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230-232.
22. TUCKER, K.L., M. MEYER & Y.A. BARDE. 2001. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4: 29-37.
23. CHAO, M.V. 2001. Trophic factors: an evolutionary cul-de-sac or door into higher neuronal function? J. Neurosci. Res. 59: 353-355.
24. LU, B. & A. FIGUROV. 1997. Role of neurotrophins in synapse development and plasticity. Rev. Neurosci. 8: 1-12.
25. TAKEI, N. & H. NAWA. 1998. Roles of neurotrophins on synaptic development and functions in the central nervous system. Hum. Cell 11: 157-165.
26. CHOUTHAI, N.S., J. SAMPERS, N. DESAI, et al. 2003. Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions. Pediatr. Res. 53: 965-969.
27. POLIN, R.A. & W.W. FOX. 1998. Fetal and Neonatal Physiology. WB Saunders. Philadelphia.